Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

This study provides valuable insight into the increasing use of obesity drugs. The rising prescription numbers suggest that ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Eli Lilly reported mixed fourth-quarter results on Thursday, surpassing earnings expectations but falling short of sales projections, even as demand for its flagship weight loss drug Zepbound and ...

Sales of Lilly’s top-selling product, the diabetes treatment Mounjaro, jumped 60% to $3.53 billion in the final quarter of ...

Obesity is a growing concern worldwide, including in low- and middle-income countries (LMICs). Addressing this issue involves various strategies, including dietary and lifestyle changes, medical ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Morrisons has said product availability is still recovering after a technology outage last year (Ian West/PA) Morrisons has said the availability of products in its stores has still not fully ...

With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly and Co ... beating Novo Nordisk in large part thanks to the availability of supply. Nonetheless, shares of Eli ...

In its first nine months of global availability last year, Zepbound, which results in weight loss of about 20 per cent over 17 months compared to 14 per cent for Wegovy, racked up sales of £2.4bn.